Option chain shows key data for Jupiter Neurosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Jupiter Neurosciences.

Jupiter Neurosciences (NASDAQ:JUNS) Stock, Option Chain

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Ciena

News

Intraday Update

Markets

Movers

Trading Ideas

BTDR

CIEN

GAMB

HIMX

JUNS

LQDT

RADX

RIOT

Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On Thursday

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences Inc

Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) has outperformed the market over the past 10 years by 15.66% on an annualized basis producing an average annual return of 27.25%. Currently, Eli Lilly has a market capitalization of $742.84 billion. 
Buying $100 In LLY: If an investor had bought $100 of LLY stock 10 years ago, it would be worth $1,129.58 today based on a price of $782.50 for LLY at the time of writing.
<h3>Eli Lilly's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734047115_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) has outperformed the market over the past 5 years by 26.55% on an annualized basis producing an average annual return of 40.14%. Currently, Ares Management has a market capitalization of $36.89 billion. 
Buying $1000 In ARES: If an investor had bought $1000 of ARES stock 5 years ago, it would be worth $5,424.16 today based on a price of $182.74 for ARES at the time of writing.
<h3>Ares Management's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734046207_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARES

$1000 Invested In Ares Management 5 Years Ago Would Be Worth This Much Today

Fixed-rate mortgage rates have steadily declined, marking a third consecutive week of decrease. Freddie Mac's data shows that 30-year <a href="https://www.benzinga.com/money/mortgages">fixed-rate mortgage</a> now averages 6.60%, significantly lower than the 6.95% rate from a year ago.
"The combination of mortgage rate declines, firm consumer income growth, and a bullish stock market have increased homebuyer demand in recent weeks. While the outlook for the housing market is improving, the improvement is limited given that homebuyers continue to face stiff affordability headwinds," <a href="https://freddiemac.gcs-web.com/news-releases/news-release-details/mortgage-rates-continue-drop-3">noted</a> Sam Khater, Freddie Mac's chief economist.
Fixed-rate mortgages are crucial for many homebuyers, particularly first-time buyers because they offer predictability. Since the interest rate remains constant throughout the loan term, borrowers know their monthly payments regardless of market conditions, making for easier financial planning and buying peace of mind. If these rates continue to drop, this development could make homeownership more accessible, stimulating sales.
<a href="https://www.nar.realtor/research-and-statistics/housing-statistics/existing-home-sales">Recent data</a> reveals that the U.S. housing market is showing signs of recovery. Existing home sales rose 3.5% in October 2024, rebounding from a 14-year low and surpassing market expectations.
However, the median home sales price increased by 4% to $407,200, outpacing November&#8217;s 2.7% inflation rate. While Khater warned about these dynamics, home prices typically rise faster than inflation, which is one reason they were excluded from the Consumer Price Index (CPI) calculation in 1983.
Falling mortgage rates support optimism for the market, which suffered high borrowing costs earlier this year. Furthermore, the National Association of Realtors Chief Economist Lawrence Yun noted increased inventory could further bolster home sales, with job growth and economic expansion supporting growing housing demand.
Still, the home construction market offered mixed results, as shown by broad market ETFs. The iShares U.S. Home Construction ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITB#BATS">ITB</a>) returned 14.66% year-to-date, while the SPDR S&amp;P Homebuilders ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHB#NYSE">XHB</a>) fared better at 23.06%. The Invesco Building &amp; Construction ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKB#NYSE">PKB</a>) outperformed with 31.86% — however, it is worth noting that it is by far the smallest and most expensive of the group.
Two notable stocks in the sector performed similarly. KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) has clocked a solid yet underperforming 18.52% return year-to-date. It trades at 8.9x its earnings, significantly lagging the peer average 21.1x.  Meanwhile, Toll Brothers Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) outperformed, climbing 37.39% year-to-date. Still, the firm trades cheaper than its peers at 8.8x its earnings. Following the <a href="https://www.benzinga.com/news/earnings/earnings-beats/24/12/42418066/toll-brothers-investors-may-be-disappointed-with-guidance-analysts-say-after-q4-earnings">latest earnings results</a>, Oppenheimer and JPMorgan reiterated an Outperform and Overweight rating, citing robust demand but warning about the gross-margin guidance for the first quarter of fiscal 2025.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42471357/egg-hyperinflation-could-spike-grocery-prices-why-cal-maine-vital-farms-are-soaring">Egg Hyperinflation Could Spike Grocery Prices: Why Cal-Maine, Vital Farms Are Soaring</a>
Photo: Shutterstock

Sector ETFs

Economics

ETFs

Real Estate

iShares Dow Jones US Homenstruction Index Fund

PowerShares ETF Trust Dynamic Building &nstruction Portfolio

Mortgage Rates Drop Present Opportunities For Homebuilders

Republic Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>) has outperformed the market over the past 20 years by 3.58% on an annualized basis producing an average annual return of 11.99%. Currently, Republic Servs has a market capitalization of $65.80 billion. 
Buying $100 In RSG: If an investor had bought $100 of RSG stock 20 years ago, it would be worth $973.73 today based on a price of $210.13 for RSG at the time of writing.
<h3>Republic Servs's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734045311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Republic Servs 20 Years Ago Would Be Worth This Much Today

Teledyne Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>) has outperformed the market over the past 10 years by 5.7% on an annualized basis producing an average annual return of 17.29%. Currently, Teledyne Technologies has a market capitalization of $22.32 billion. 
Buying $100 In TDY: If an investor had bought $100 of TDY stock 10 years ago, it would be worth $491.95 today based on a price of $478.96 for TDY at the time of writing.
<h3>Teledyne Technologies's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734044409_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Teledyne Technologies Stock In The Last 10 Years

Canada is considering export taxes on goods, including uranium, oil and potash, if President-elect Donald Trump imposes the broad<a href="https://www.benzinga.com/news/global/24/12/42451262/canadian-oil-sector-hedges-trump-tariff-risk-us-midwest-refineries-could-be-affected"> tariffs he pledged. </a>
The Details: According to a Bloomberg <a href="https://www.bloomberg.com/news/articles/2024-12-12/canada-weighs-export-taxes-on-uranium-oil-if-trump-starts-trade-war?srnd=homepage-americas">report</a>, retaliatory tariffs on U.S.-made goods and export controls on certain Canadian products are most likely, with export levies also on the table as a last resort. The Bloomberg report cited officials familiar with discussions inside Prime Minister Justin Trudeau's government.&nbsp;
The sources also said Trudeau's government may consider expanding its powers over export controls as part of a scheduled update on the country's fiscal and economic conditions.&nbsp;
Why It Matters: U.S. oil refineries, especially in the Midwest, rely heavily on Canadian crude oil imports. Export levies would increase the cost of imported Canadian oil and potentially squeeze refinery margins. Some of the largest oil refiners in the U.S. are Marathon Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) and Valero Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>). 
Read Next: <a href="https://www.benzinga.com/news/global/24/12/42451262/canadian-oil-sector-hedges-trump-tariff-risk-us-midwest-refineries-could-be-affected">Canadian Oil Sector Hedges Trump Tariff Risk, US Midwest Refineries Could Be Affected</a>
Canadian export taxes on uranium could be devastating to U.S. nuclear energy producers with Canada supplying about a quarter of the uranium U.S. producers use for their nuclear reactors.&nbsp;
Constellation Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>), the largest owner of non-rate-regulated nuclear plants in the U.S., and Duke Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>), which operates 11 nuclear units in North and South Carolina, could face supply disruptions as domestic uranium production is virtually nonexistent. The companies could pass along the increased costs to consumers in areas served by nuclear power plants.
American farmers rely heavily on imports of Canadian potash as a source of fertilizer. If Canada imposes export levies on potash,&nbsp;several American farm-related stocks could be affected due to the reliance of U.S. agriculture on the fertilizer.
Companies tied to crops heavily dependent on potash, such as soybeans, corn, sugar beets and potatoes could see increased costs. These companies include Archer-Daniels-Midland Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) and Bunge Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>). Food producers, like General Mills, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) and Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>) may face higher input costs for agricultural products reliant on potash fertilizers and could pass those costs along to consumers.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42370672/sofi-makes-spacex-accessible-for-retail-investors">SoFi Unlocks SpaceX Exposure For Retail Investors: Here&#8217;s How</a></li>
</ul>
Image: Shutterstock

Commodities

Politics

Global

If Trump Starts A Trade War, Canada Could Impose Export Taxes On Oil, Uranium: Report

Dividends

Lument Finance Trust Declares One-time Special Cash Dividend Of $0.09 Per Share Of Common Stock Due To Real Estate Investment Trust Tax Considerations

Delek Logistics Partners Reports Development Of Permitted Acid Gas Injection 'AGI' Capabilities At Its Under-construction Libby 2 Gas Processing Plant

The property is located in a strong retail corridor in Indiana and corporate-operated under a triple net lease with approximately four years of term remaining. The transaction was priced at a 6.8% cap rate on rent as of the closing date and exclusive of transaction costs.

FCPT

Four Corners Property Trust Reveals Acquisition Of A Panera Bread Property For $2M

Equinix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EQIX#NASDAQ">EQIX</a>) has outperformed the market over the past 15 years by 3.9% on an annualized basis producing an average annual return of 15.91%. Currently, Equinix has a market capitalization of $94.10 billion. 
Buying $100 In EQIX: If an investor had bought $100 of EQIX stock 15 years ago, it would be worth $932.23 today based on a price of $975.30 for EQIX at the time of writing.
<h3>Equinix's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734043515_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EQIX

Here's How Much You Would Have Made Owning Equinix Stock In The Last 15 Years

Program to support EVgo's forthcoming efforts to build convenient, reliable public charging infrastructure for electric vehicles (EVs) with the construction of 7,500 new fast charging stalls nationwide.
This buildout will bring EVgo's total owned and operated network to at least 10,000 fast charging stalls, allowing the Company to more than triple its network footprint by 2029.

EVGO

EVgo Closes Its $1.25B Guaranteed Loan Facility From US Department Of Energy Loan Programs Office

The late-stage pipeline includes oveporexton (TAK-861), zasocitinib (TAK-279), rusfertide (TAK-121), mezagitamab (TAK-079), fazirsiran (TAK-999) and elritercept (TAK-226). Combined these programs have potential peak revenue of $10B - $20B. Data from three Phase 3 programs is expected to read out in 2025.

Guidance

Takeda Plans To Host An Investor R&D Day; Expects Six Late-Stage Programs With Peak Revenue Potential Of $10B - $20B To Deliver Sustainable Growth

Cintas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) has outperformed the market over the past 15 years by 13.05% on an annualized basis producing an average annual return of 25.07%. Currently, Cintas has a market capitalization of $85.33 billion. 
Buying $100 In CTAS: If an investor had bought $100 of CTAS stock 15 years ago, it would be worth $2,941.81 today based on a price of $211.59 for CTAS at the time of writing.
<h3>Cintas's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734042623_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTAS

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

Earnings

Natuzzi Q3 Total Net Sales €75M, Nearly Flat With 3Q 2023

The first-quarter 2025 dividend is payable March 7, 2025, to holders of the Common Stock of record at the close of business on January 24, 2025.&nbsp;

Pfizer Increases Quarterly Cash Dividend From $0.42 To $0.43 Per Share

APS President Ted Geisler will assume the roles of Chairman of the Board, President and CEO of Pinnacle West and APS effective April 1, 2025. Guldner will remain employed by Pinnacle West in a non-executive advisory capacity to support a smooth transition through the end of March 2026.

Management

Pinnacle West Capital Announce Jeff Guldner Will Retire As Chairman Of Board, CEO And Board Member On March 31, 2025; Ted Geisler To Assume The Roles Effective April 1, 2025

The Company is also in negotiations for the potential sale of its interests in one of its midstream assets, with total consideration, if the transaction is finalized, approved and closed, expected to be under $100 million.

CVR Energy Says Certain Of Its Wholly Owned Subsidiaries Have Priced Proposed $325M Senior Secured Term Loan B Due 2027

ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) has outperformed the market over the past 10 years by 9.8% on an annualized basis producing an average annual return of 21.39%. Currently, ON Semiconductor has a market capitalization of $28.58 billion. 
Buying $100 In ON: If an investor had bought $100 of ON stock 10 years ago, it would be worth $701.62 today based on a price of $67.11 for ON at the time of writing.
<h3>ON Semiconductor's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734041719_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In ON Semiconductor 10 Years Ago Would Be Worth Today

Brigit, which offers a subscription-based model, was launched nationally in 2019.
Upbound is acquiring Brigit for up to $460 million, comprised of (1) $325 million payable at closing, 75% in cash and 25% in Upbound shares; (2) $75 million in deferred cash consideration over two years; and (3) a potential earnout of up to $60 million in cash based on achievement of certain financial performance metrics for the Brigit business in 2026.
The acquisition is expected to close in Q1 2025, subject to receipt of requisite regulatory approvals and satisfaction of other customary closing conditions.
 &nbsp;

UPBD

Upbound Group Agrees To Acquire Financial Health Technology Company Brigit For Total Consideration Of Up To $460M In Cash And Stock

RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) reported financial results for the third quarter Thursday after the bell. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/24/12/b42471776/rh-reports-third-quarter-fiscal-2024-results">of the report</a>.
Q3 Earnings: RH reported third-quarter revenue of $811.73 million, missing the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $812.16 million, according to&nbsp;<a href="http://pro.benzinga.com" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>. The luxury retailer reported third-quarter adjusted earnings of $2.48 per share, missing analyst estimates of $2.65 per share.
Despite reporting headline numbers that fell short of analyst estimates, RH shares are soaring after hours on what appears to be a reaction to strong guidance. 
RH raised revenue guidance across the board based on current trends. The company expects fourth-quarter demand growth of 20% to 22%, and fourth-quarter revenue growth of 18% to 20%.
RH also raised its full-year outlook. The company now expects full-year demand to grow between 9.9% and 10.4%. RH expects full-year revenue growth of 6.8% to 7.2%.
&#8220;The positive inflection of our business continued to gain momentum with third-quarter demand increasing 13% despite operating in the worst housing market in 30 years. Our vector is increasing in both magnitude and direction with November demand up 18%, as the most prolific product transformation and platform expansion in the history of our industry continues to unfold,&#8221; the company said in a letter to shareholders.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/12/42472970/broadcom-reports-mixed-q4-results-eps-beat-revenues-miss-q1-guidance-in-line-with-estimates">Broadcom Reports Mixed Q4 Results: EPS Beat, Revenues Miss, Q1 Guidance In Line With Estimates</a>
RH said demand jumped 24% in November and has continued to accelerate in December with demand up 30% month-to-date. The company also provided positive commentary on the impacts of potential tariffs as it continues to move operations out of China. 
&#8220;We do not expect a negative impact to margins as a result of the most recent communications regarding the potential for increased tariffs in 2025. We have been proactively moving sourcing away from China over the past several years with the expectation of fully exiting the country by the end of the second quarter,&#8221; the company said. 
RH Price Action: <a href="http://benzinga.com/quote/rh">RH shares</a> were up 16.68% in after-hours, trading at $445 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo:&nbsp;<a href="https://pixabay.com/users/jessebridgewater-4820770/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=2400367">Jesse Bridgewater</a> from Pixabay.

Comments

Jupiter Neurosciences

Jupiter Neurosciences (JUNS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga